VSIG10L2
V-set and immunoglobulin domain-containing protein 10-like 2
Also known as: VSXL2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DP72
- Gene
- VSIG10L2
- Ensembl
- ENSG00000283703
- Chromosome
- 11
- Canonical length
- 767 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be located in membrane. Predicted to be active in cell-cell junction and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
767 residues, UniProt reviewed canonical sequence.
>P0DP72|VSIG10L2
1 MVGQRAQHSP VSLLLLIHLC LLHLRASGQP HPTPEAPVEE VVSVQGVRGG SVELACGSGP
61 APLLVLWSFT PLGSLVPRPV AVTDGAMSKV EAIASALGVV SLRNSSLVLG ELHEGARGHF
121 LCQVLHVAGG QLHAAYSHLT LAVLVPVSKP QVRLSNPSPV EGASVVATCA VREGTEPVTF
181 AWQHRAPRGL GEALVGVTEP LFQLDPVNRT HLGWYMCSAS NSVNRLSSDG AFLDVIYGPD
241 KPVITMEPLG LTEEGFWASE REEVTLSCLA ASNPPSHYVW LRDHTQVHTG PTYVIARAGR
301 VHTGLYTCLA RNSYLDTRTQ TTVQLTIYYP PEGQPSCAVH PSPEAVTLLC AWPGGLPPAQ
361 LQWEGPQGPG PTAPSNVTWS HAAAQLPSGS VFTCTGQHPA LAPPALCTVM LWEPLGRPTC
421 WSTATMGDQF IMLSCEWPGG EPPATLGWLD EQQQPLGGSS SSMAVHLLQA QEDLAGREFT
481 CRGTHLLRTP DPHCHLQLEA PQLDVAEPRV SVLEGGEAWL ECSLRGGTPP AQLLWLGPQQ
541 QKVDPGTSGF MLHPEGAQLR LGIYDADPAH HRGTYQCVAR NAVGNSSQSV LLEVLRYPAP
601 PNVTISRLTY GRHRREVQLQ WAILGPGNLT GFLVQRKASA LGPGAGAWET AASDIEPESR
661 GRRLGGLDPG VLYAFRILAL NHHTAGHPSE VKIPADPPFS AYPAVLGAAG TGMVVATVAS
721 LLVFQYAARH PETFPRLETP TTTPGLDPAQ ETTDSPVNVT ITVTATPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VSIG10L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- skin: 17 nTPM
- cerebellum: 4.4 nTPM
- cervix: 2.4 nTPM
- breast: 1.8 nTPM
- vagina: 1.5 nTPM
- colon: 1.4 nTPM
Single-cell type
- epicardial cells: 127 nCPM
- mesothelial cells: 32 nCPM
- breast hormone-responsive cells: 24 nCPM
- suprabasal keratinocytes: 21 nCPM
- basal keratinocytes: 16 nCPM
- fibro-adipogenic progenitors: 16 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 8.2 nTPM
- cerebral cortex: 3.4 nTPM
- pons: 2 nTPM
- hippocampal formation: 1.9 nTPM
- basal ganglia: 1.8 nTPM
- hypothalamus: 1.7 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VSIG10L2 as an antibody target. Whether an autoantibody or antibody against VSIG10L2 could matter depends on whether native VSIG10L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VSIG10L2 is annotated at the cell surface, where native VSIG10L2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label VSIG10L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...